molecules-logo

Journal Browser

Journal Browser

Recent Developments and Therapeutic Potential of Quinoline Derivatives

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".

Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 188

Special Issue Editors


E-Mail Website
Guest Editor
Laboratory of Applied Chemistry and Environment, Faculty of Sciences, Mohammed Premier University, Oujda, Morocco
Interests: organic chemistry; catalysis; natural products
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Chemistry, College of Sciences, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia
Interests: molecular docking; DFT; theoretical studies; ADME studies; synthesis; bioactive molecules
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The quinoline nucleus is one of the most essential nuclei in medicinal, pharmaceutical, and organic chemistry. Quinoline and its derivatives have many applications, such as anti-cancer, antioxidant, anti-inflammatory, antimalarial, and recently anti-COVID-19 applications as well as many other medicinal applications that are important in medicinal chemistry industries. Additionally, as the trend of perserving the Earth using green and sustainable synthetic methods and decreasing the use of the traditional methods continue to become more pertinent, one of our aims is to determine new sustainable methods for quinoline synthesis.
Our goal in this Special Issue is to collect articles and connect researchers in the field of the synthesis and in the investigation of quinolines. This may prove useful in the medicinal chemistry industry.

We invite all organic, pharmaceutical, and medicinal chemists to share and publish their work in this Special Issue.

Prof. Dr. Rachid Touzani
Dr. Magda Abdellattif
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • quinolines
  • organic synthesis
  • molecular modeling
  • computational studies
  • biological applications
  • pharmaceutical applications
  • therapeutics
  • green and sustainable methods

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop